Sort
25,944 grants matching “neurodegeneration”
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)
$716,897Robert Lee Newton · Lsu Pennington Biomedical Research Ctr · R01 · FY2020 · AG
Entorhinal-hippocampal interactions during progressive memory impairments in mouse models of Alzheimer's disease pathology
$716,760Tristan Shuman · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · AG
Safety and modulation of ABCC9 pathways by nicorandil for the treatment of hippocampal sclerosis of aging (SMArTâÂÂHS)
$716,551Gregory A Jicha · University Of Kentucky · R01 · FY2022 · AG
Systematic Study of Extracellular Vesicles and their Integrative Analysis with Parkinson's Organoids MAP
$716,225Luke P. Lee · Brigham And Women'S Hospital · R01 · FY2024 · NS
Systematic profiling of lysosomes with age to improve proteostasis in Alzheimer's
$716,147Aimee Kao · University Of California, San Francisco · R01 · FY2019 · AG
Morphologic/Neurochemical Correlates of Depression in AD
$715,770University Of Pittsburgh At Pittsburgh · R01 · FY2005 · MH
Molecular Basis for the Pathogenesis of Murine Retroviruses
$715,740Sandra K Ruscetti · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Amyloid Beta CAR Macrophages: a cell engineering strategy to clear pathogenic proteins
$715,640Saar Gill · University Of Pennsylvania · R01 · FY2024 · NS
THE GENETICS AND MULTI-OMICS SPECIMENS CORE (GMSC)
$715,632Carlos Cruchaga · Washington University · U19 · FY2022 · AG
Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)
$715,602Robert Lee Newton · Lsu Pennington Biomedical Research Ctr · R01 · FY2019 · AG
Establishment of a transgenic monkey of Huntingtons's diesease
$715,487Anthony Wing Sang Chan · Emory University · R24 · FY2011 · RR
Alzheimer's disease drug development
$715,227Nigel H. Greig · National Institute On Aging · ZIA · FY2023 · AG
Neuroprotection by IFN-beta in AIDS
$715,213Marcus Kaul · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · MH
Develop an ANS-based Personalized Cognitive Training for Mild Cognitive Impairment
$715,167Feng Vankee Lin · Stanford University · R33 · FY2023 · AG
Silent brain ischemia accelerates Alzheimer's dementia: pathogenesis and laser treatment
$715,072Quanguang Zhang · Louisiana State Univ Hsc Shreveport · R01 · FY2025 · AG
Advancing novel therapies for optic neuropathy with a nonhuman primate model
$715,063Sara Michelle Thomasy · University Of California At Davis · R01 · FY2025 · EY
COBRE: U NEL: ADMIN: NEBRASKA REDOX BIOLOGY CENTER
$715,007Vadim N. Gladyshev · University Of Nebraska Lincoln · P20 · FY2009 · RR
SAFE TREATMENT FOR TBI-INDUCED NEURODEGENERATION AND COGNITIVE DECLINE
$714,986President And Fellows Of Harvard College · · FY2025 · Defense Health Agency
Tau-seed protein interactome and its role in neurodegenerative tauopathies
$714,701Cristian Lasagna-Reeves · Indiana University Indianapolis · R01 · FY2020 · NS
Brain-penetrating acetylcholinesterase reactivators for several organophosphates
$714,669Janice E. Chambers · Mississippi State University · U01 · FY2015 · NS
Iron as an Imaging Biomarker for Inflammation in AD
$714,464Michael M Zeineh · Stanford University · R01 · FY2019 · AG
24-hour Activity Cycles to Optimize Cognitive Resilience to Alzheimer's Disease in African Americans: The Jackson Heart Study
$714,316Kelley Pettee Gabriel · University Of Alabama At Birmingham · R01 · FY2023 · AG
Investigating the combined role of APOE4 and ketogenic diets in Alzheimer's disease
$714,224Joel William Blanchard · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
The role of DNA damage in human disease: Neurodegeneration and Cancer
$714,119Philip J Brooks · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2010 · AA
Tau proteostasis by chaperone-complexes in tauopathies including Alzheimer's disease
$714,107Manu Sharma · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AG